Showing results (591-600 of 1,837) with videos related to

Sort By:
Pageof 184
ESMO Open|November 7, 2025
Zanidatamab in combination with docetaxel in first-line HER2-positive breast cancer: results from an open-label, multicenter, phase Ib/II studyX Wang, K S Lee, X Zeng, et al.
ESMO Open|November 7, 2025
Retreatment, rechallenge, and escalation with subsequent immune checkpoint inhibitor therapies across cancers after initial failureI P da Silva, L Zimmer, J-Y Blay, et al.
ESMO Open|November 12, 2025
Phase I trial of neratinib plus palbociclib in advanced cancers with HER family alterationsS A Piha-Paul, C Tseng, H T Tran, et al.
ESMO Open|December 6, 2025
Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trialM Bartoletti, A Passarelli, A Fagotti, et al.
ESMO Open|September 18, 2025
Access to novel cancer medicines in Europe: inequities across countries and their driversT Hofmarcher, A Charalambous, N Normanno, et al.
ESMO Open|September 24, 2025
Early detection, clinicopathological subtyping, and prognosis prediction for endometrial cancer patients using fragmentomics liquid biopsy assayQ Rao, H Zhou, W Weng, et al.
ESMO Open|September 13, 2025
Assessing targetable NTRK1/2/3 fusions in mesenchymal tumors via whole-exome RNA sequencingH Vanacker, M Brahmi, D Pissaloux, et al.
ESMO Open|September 10, 2025
Occurrence of dMMR/MSI-H tumor during follow-up in Lynch syndrome patients treated with immune checkpoint inhibitors for metastatic digestive cancer between 2015 and 2024: a retrospective analysis of a monocentric prospective cohort studyA Pellat, C Loisel, J Metras, et al.
ESMO Open|September 12, 2025
Exploring the impact of NGS on diagnostics and treatment of sarcoma: insights from real-world data across multiple institutions in EuropeA Kyriazoglou, A Zając, C Valverde, et al.
ESMO Open|September 12, 2025
A phase I study of AZD8186 in combination with docetaxel in patients with PTEN-mutated or PIK3CB-mutated advanced solid tumorsA M Schram, N Takebe, A Chen, et al.
Pageof 184